Exhibit 99.1

[GRAPHIC OMITTED]
 VALLEY FORGE
  SCIENTIIC

                                                           FOR IMMEDIATE RELEASE


                  VALLEY FORGE SCIENTIFIC AND SYNERGETICS, INC.
                            ANNOUNCE MERGER AGREEMENT

OAKS, PA, May 3, 2005 -- Valley Forge Scientific Corp. (NASDAQ: VLFG; BSE: VLF)
and Synergetics, Inc., a privately-held corporation, announced today that they
have entered into a definitive merger agreement to combine the two companies.
Under the terms of the merger agreement, Synergetics' shareholders will receive
in the aggregate approximately 16 million shares of Valley Forge common stock.
Upon completion of the transaction, Synergetics' former shareholders will
represent approximately 66 percent of Valley Forge's outstanding common stock on
a fully diluted basis.

         For the fiscal year ended September 30, 2004, Valley Forge had revenues
of approximately $4.8 million, and for the fiscal year ended July 31, 2004,
Synergetics had revenues of approximately $16.9 million. The merger is subject
to satisfaction of a number of closing conditions, including shareholder and
regulatory approvals, and is anticipated to close in the third quarter of 2005.
The closing price of Valley Forge's common stock on April 29, 2005 was $1.90.

         Shareholders of Valley Forge holding approximately 35 percent of
outstanding shares of Valley Forge common stock and shareholders of Synergetics
holding approximately 19 percent of shares of Synergetics common stock have
agreed to vote in favor of the merger.

         Synergetics and Valley Forge believe that the merger will result in a
larger and stronger company with both the products and the sales and
distribution network to become a greater presence in the medical device
industry. The combined company will have the resources to expand into markets
that the companies on their own would not be able to achieve as rapidly.

         Valley Forge Chairman and CEO Jerry L. Malis said, "We believe that
this transaction creates significant value for our shareholders and provides
excellent opportunities for growth for the combined company, which Valley Forge
could not accomplish on its own. Synergetics has an experienced management team,
an established presence in the retina surgery and neurosurgery markets, as well
as other microsurgery markets for medical instrument sales. The company also has
developed a sales and distribution network, which we are confident will thrive
with Valley Forge's product line. We believe Synergetics' business complements
the existing business of Valley Forge. We see this as the right move at the
right time for Valley Forge."


         Synergetics President and CEO Gregg D. Scheller said, "The combined
company will give us the ability to design, develop, and manufacture electronic
based products and instruments and sell those products directly into the market.
Valley Forge has a strong brand name in neurosurgery and a broad base of
proprietary products that we expect will benefit substantially under the
domestic and international distribution network that Synergetics has built over
the last 13 years. The merger will also give the combined company the ability to
develop new products, utilizing Valley Forge's depth of knowledge in electronics
and bipolar electrosurgery and Synergetics' knowledge in disposable technology."

         Pursuant to the merger agreement, management of the new company will
consist of executives of both companies and be led by a management team
consisting of Gregg D. Scheller as President and CEO (currently the CEO of
Synergetics), Jerry L. Malis, as Executive Vice President and Chief Scientific
Officer (currently the CEO and President of Valley Forge) and Kurt W. Gampp,
Jr., Executive Vice President and COO (currently the Executive Vice President
and COO of Synegetics), and the Board of Directors will be composed of seven
directors, including two current directors of each of Synergetics and Valley
Forge and three additional independent directors. Four of the seven directors
will be independent.

         The Boards of Directors of both Valley Forge and Synergetics have
approved the definitive merger agreement. Valley Forge will seek stockholder
approval of the transaction at its annual meeting and Synergetics will hold a
special meeting of shareholders to consider approval of the transaction. The
dates of the shareholder meetings will be announced following completion of
initial regulatory filings.

About Synergetics, Inc.

         Synergetics, Inc. is a privately-held corporation that that is involved
in the development, manufacture, and sales of durable and disposable instruments
for use in retina surgery, neurosurgery and other microsurgery markets.
Synergetics, Inc. is a vertically integrated manufacturer with an established
distribution network through independent and direct sales organizations selling
its products into more than 60 countries. Synergetics has significant market
presence in retinal surgery instruments and disposables. Synergetics also
distributes and manufactures proprietary disposables for Sonopet OMNI Surgical
Aspirator in neurosurgery.

                                       2


About Valley Forge Scientific Corp.

         Valley Forge has established itself as a leading developer and
manufacturer of bipolar electrosurgical systems and related instrumentation.
Based on its DualWave(TM) technology, these systems provide surgeons with the
ability to safely cut and coagulate tissue in the most critical areas of the
brain and spinal cord. Valley Forge's bipolar electrosurgery systems are based
on technology developed in conjunction with Leonard I. Malis, MD, Professor and
Chairman Emeritus of the Mount Sinai School of Medicine Department of
Neurosurgery.

IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC

         Valley Forge plans to file with the SEC a Registration Statement on
Form S-4 in connection with the transaction, and Valley Forge and Synergetics
plan to file with the SEC and to mail to their respective stockholders a Joint
Proxy Statement/Prospectus in connection with the transaction. The Registration
Statement and the Joint Proxy Statement/Prospectus will contain important
information about Valley Forge, Synergetics, the transaction and related
matters. Investors and security holders are urged to read the Registration
Statement and the Joint Proxy Statement/Prospectus carefully when they are
available.

         These securities may not be sold, nor may offers to buy be accepted,
prior to the time the registration statement becomes effective. This
announcement shall not constitute an offer to sell or the solicitation of an
offer to buy, nor shall there be any sale of these securities in any state in
which such offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state.

         Investors and security holders will be able to obtain free copies of
the Registration Statement and the Joint Proxy Statement/Prospectus (when
available) and other documents filed with the SEC by Valley Forge through the
web site maintained by the SEC at www.sec.gov.

         In addition, investors and security holders will be able to obtain free
copies of the Registration Statement and the Joint Proxy Statement/Prospectus
(when available) and other documents filed with the SEC from Valley Forge by
contacting Investor Relations for Valley Forge at telephone number 610.666.7500.

         Valley Forge and Synergetics, and their respective directors and
executive officers, may be deemed to be participants in the solicitation of
proxies in respect of the transactions contemplated by the merger agreement.
Information regarding Valley Forge's directors and executive officers is
contained in Valley Forge's Form 10-K for the year ended September 30, 2004,
which is filed with the SEC and available free of charge as indicated above. The
interests of Valley Forge's and Synergetics' respective directors and executive

                                       3


officers in the solicitations with respect to the transactions in particular
will be more specifically set forth in the Registration Statement and the Joint
Proxy Statement/Prospectus to be filed with the SEC, which will be available
free of charge as indicated above.

Forward-Looking Statements

         Some statements in this announcement may be "forward-looking
statements" for the purposes of the Private Securities Litigation Reform Act of
1995. In some cases, forward-looking statements can be identified by words such
as "believe", "expect", "anticipate", "plan", "potential", "continue" or similar
expressions. Such forward-looking statements are based upon current expectations
and beliefs and are subject to a number of factors. These forward-looking
statements are subject to risks and uncertainties that may cause actual results
to differ materially from those indicated in the forward-looking statements,
including but not limited to: (i) the possibility that the transaction will not
close or that the closing will be delayed due to regulatory review or other
factors; (ii) the challenges and costs of combining the operations and personnel
of Synergetics with Valley Forge; (iii) the ability to attract and retain highly
qualified employees; (iv) competitive factors, including pricing pressures; (v)
reaction of customers of Valley Forge and Synergetics and end-users of their
products and related risks of maintaining pre-existing relationships of Valley
Forge and Synergetics; (vi) fluctuating currency exchange rates; (vii) adverse
changes in general economic or market conditions; and (viii) other one-time
events and other important factors disclosed previously and from time to time in
Valley Forge's filings with the SEC and to be more specifically set forth in the
Joint Proxy Statement/Prospectus to be filed by Valley Forge and Synergetics
with the SEC. Valley Forge and Synergetics disclaim any obligation to update any
forward-looking statements after the date of this release.

                                      # # #

                                       4